A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)
Clinical trial NCT05088460 · TERMINATED
Trial details
- NCT number
- NCT05088460
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-28
- Primary completion
- 2023-12-13
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.